iFundanet
Funding Opportunities
Contact
Home | Actualitat | | Sant Pau and IMIM researchers discover a new biomarker, the sLRP1 receptor, which predicts the risk of developing cardiovascular disease in people who currently have no symptoms

CURRENT AFFAIRS

X
Jul'19 02

02/07/2019

Sant Pau and IMIM researchers discover a new biomarker, the sLRP1 receptor, which predicts the risk of developing cardiovascular disease in people who currently have no symptoms

http://www.madrimasd.org/notiweb/noticias/los-microrna-circulantes-biomarcadores-clave-diagnostico-los-pacientes-enfermedad-coronaria-estable

http://biotech-spain.com/en/articles/the-circulating-microrna-key-biomarkers-for-the-diagnosis-of-patients-with-stable-coronary-heart-disease/

https://www.medicina21.com/Notas_De_Prensa/V13766/Los-microRNA-circulantes-biomarcadores-clave-para-el-diagnostico-de-los-pacientes-con-enfermedad-coronaria-estable.html

https://www.farmanews.com/Notasprensa/13766/Los_microRNA_circulantes_biomarcadores_clave_para_el_diagnos

https://www.consalud.es/pacientes/los-microrna-circulantes-clave-en-el-diagnostico-de-los-pacientes-con-enfermedad-coronia-estable_65857_102.html

https://www.infosalus.com/salud-investigacion/noticia-microrna-circulantes-biomarcadores-clave-diagnostico-pacientes-enfermedad-coronaria-estable-20190702132714.html

http://www.diariosigloxxi.com/texto-ep/mostrar/20190702132714/microrna-circulantes-biomarcadores-clave-diagnostico-pacientes-enfermedad-coronaria-estable

https://noticias.medicinatv.com/los-microrna-circulantes-biomarcadores-clave-para-el-diagnostico-de-los-pacientes-con-enfermedad-coronaria-estable

https://www.bolsamania.com/noticias/sanidad/los-microrna-circulantes-biomarcadores-clave-para-el-diagnostico-de-los-pacientes-con-enfermedad-coronaria-estable–6784344.html

https://www.actasanitaria.com/microrna-circulantes-patologia-coronaria/

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information

I agree